Prast H, Tran M H, Fischer H, Philippu A
Department of Pharmacology and Toxicology, University of Innsbruck, Austria.
J Neurochem. 1998 Jul;71(1):266-73. doi: 10.1046/j.1471-4159.1998.71010266.x.
We have previously shown that the basal acetylcholine release in the ventral striatum is under the enhancing influence of endogenous nitric oxide (NO) and that NO donors cause pronounced increases in the acetylcholine release rate. To investigate the role of cyclic GMP, glutamate, and GABA in the NO-induced acetylcholine release, we superfused the nucleus accumbens, (Nac) of the anesthetized rat with various compounds through a push-pull cannula and determined the neurotransmitter released in the perfusate. Superfusion of the Nac with the NO donors diethylamine/NO (DEANO; 100 micromol/L), S-nitroso-N-acetylpenicillamine (SNAP; 200 micromol/L), or 3-morpholinosydnonimine (SIN-1; 200 micromol/L) enhanced the acetylcholine release rate. The guanylyl cyclase inhibitor 1H-(1,2,4)-oxodiazolo(4,3-a)quinoxalin-1-one (ODQ; 10 micromol/L) abolished the effects of DEANO and SIN-1. 6-(Phenylamino)-5,8-quinolinedione (LY-83583; 100 micromol/L), which also inhibits cyclic GMP synthesis, inhibited the releasing effects of DEANO and of SNAP, whereas the effect of SIN-1 on acetylcholine release was not influenced. The DEANO-induced release of acetylcholine was also abolished in the presence of 20 micromol/L 6,6-dinitroquinoxaline-2,3-dione (DNQX) and 10 micromol/L (+/-)-2-amino-5-phosphonopentanoic acid (AP-5). Simultaneous superfusion with 50 micromol/L quinpirole and 10 micromol/L 7-bromo-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SKF 83566) was ineffective. Superfusion with 500 micromol/L DEANO decreased the release of acetylcholine. The inhibitory effect of 500 micromol/L DEANO was reversed to an enhanced release on superfusion with 20 micromol/L bicuculline. Bicuculline also enhanced the basal release rate. These findings indicate that cyclic GMP mediates the NO-induced release of acetylcholine by enhancing the outflow of glutamate. Dopamine is not involved in this process. Only high concentrations of NO increase the output of GABA, which in turn decreases acetylcholine release. Our results suggest that cells that are able to release glutamate, such as glutamatergic neurons, are the main target of NO in the Nac.
我们之前已经表明,腹侧纹状体中的基础乙酰胆碱释放受到内源性一氧化氮(NO)的增强影响,并且NO供体可导致乙酰胆碱释放速率显著增加。为了研究环鸟苷酸(cGMP)、谷氨酸和γ-氨基丁酸(GABA)在NO诱导的乙酰胆碱释放中的作用,我们通过推挽式插管将各种化合物灌注到麻醉大鼠的伏隔核(Nac)中,并测定灌注液中释放的神经递质。用NO供体二乙胺/NO(DEANO;100微摩尔/升)、S-亚硝基-N-乙酰青霉胺(SNAP;200微摩尔/升)或3-吗啉代亚硝基胍(SIN-1;200微摩尔/升)灌注Nac可提高乙酰胆碱释放速率。鸟苷酸环化酶抑制剂1H-(1,2,4)-恶二唑并(4,3-a)喹喔啉-1-酮(ODQ;10微摩尔/升)消除了DEANO和SIN-1的作用。同样抑制cGMP合成的6-(苯胺基)-5,8-喹啉二酮(LY-83583;100微摩尔/升)抑制了DEANO和SNAP的释放作用,而SIN-1对乙酰胆碱释放的作用未受影响。在存在20微摩尔/升6,6-二硝基喹喔啉-2,3-二酮(DNQX)和10微摩尔/升(±)-2-氨基-5-膦酰基戊酸(AP-5)的情况下,DEANO诱导的乙酰胆碱释放也被消除。同时用50微摩尔/升喹吡罗和10微摩尔/升7-溴-8-羟基-3-甲基-1-苯基-2,3,4,5-四氢-1H-3-苯并氮杂卓(SKF 83566)灌注无效。用500微摩尔/升DEANO灌注会降低乙酰胆碱的释放。500微摩尔/升DEANO的抑制作用在用20微摩尔/升荷包牡丹碱灌注时转变为释放增强。荷包牡丹碱也提高了基础释放速率。这些发现表明,cGMP通过增强谷氨酸的外流介导NO诱导的乙酰胆碱释放。多巴胺不参与此过程。只有高浓度的NO会增加GABA的输出,进而降低乙酰胆碱释放。我们的结果表明,能够释放谷氨酸的细胞,如谷氨酸能神经元,是Nac中NO的主要作用靶点。